Boston Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-33,484
Closed -$2.15M 763
2018
Q4
$2.15M Buy
+33,484
New +$2.47M ﹤0.01% 536
2018
Q1
Sell
-150,174
Closed -$15.7M 797
2017
Q4
$15.7M Sell
150,174
-47,642
-24% -$5.38M 0.02% 341
2017
Q3
$28.8M Buy
197,816
+17
+0% +$2.32K 0.04% 279
2017
Q2
$25.7M Sell
197,799
-62
-0% -$7.6K 0.03% 289
2017
Q1
$24.6M Buy
197,861
+541
+0.3% +$64.7K 0.03% 295
2016
Q4
$22.8M Buy
197,320
+7,762
+4% +$864K 0.03% 313
2016
Q3
$19.8M Buy
+189,558
New +$20.5M 0.03% 325
2016
Q2
Sell
-113,883
Closed -$11.4M 778
2016
Q1
$11.4M Buy
113,883
+64,370
+130% +$6.63M 0.02% 362
2015
Q4
$5.93M Sell
49,513
-3
-0% -$347 0.01% 458
2015
Q3
$5.36M Sell
49,516
-154,767
-76% -$19.2M 0.01% 472
2015
Q2
$23.6M Buy
204,283
+113,083
+124% +$12.9M 0.03% 282
2015
Q1
$10.5M Buy
91,200
+1,800
+2% +$215K 0.02% 399
2014
Q4
$10M Sell
89,400
-89,994
-50% -$9.49M 0.02% 406
2014
Q3
$17M Sell
179,394
-63,851
-26% -$5.76M 0.03% 310
2014
Q2
$20.9M Sell
243,245
-205
-0.1% -$15.6K 0.04% 282
2014
Q1
$17M Buy
+243,450
New +$19.3M 0.03% 314

Other funds holding CELG

Boston Partners's CELG Position: Q1 2019 in Review

Boston Partners sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 33,484 shares — an estimated $2.15M sold.

Boston Partners first reported a position in CELG in Q1 2014 and held it in 16 quarters. The position peaked at $28.8M in Q3 2017. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Boston Partners reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Boston Partners sold 33,484 Celgene Corp shares in Q1 2019, an estimated $2.15M.
  • Boston Partners first reported a position in Celgene Corp in Q1 2014 and held it in 16 quarters.
  • Boston Partners's Celgene Corp position peaked at $28.8M in Q3 2017.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Boston Partners's 13F filing for Q1 2019, filed 3 May 2019.